|Posted:||April 8, 2019 03:14 PM|
|From:||Representative Seth M. Grove|
|To:||All House members|
|Subject:||Updating the Pharmacy and Therapeutics Committee|
|In the near future, I plan to introduce legislation making updates to the current membership of the Pharmacy and Therapeutics (P & T) Committee within the Department of Human Services (DHS).
The department created the P&T Committee to act in an advisory capacity to DHS and the Office of Medical Assistance Programs. The committee also makes recommendations relating to the department’s Preferred Drug List (PDL) used for purchasing drugs through the state’s Medical Assistance program (Medicaid). The recommendations made by the committee include new drugs for existing classes under the PDL, changes in the status of drugs on the PDL, new quantity limits and classes of drugs to be added to or deleted from the PDL.
Currently, the committee is comprised of medical directors from DHS along with external physicians and pharmacists from managed care organizations. My legislation would expand the committee to include both legislators and community pharmacists. This expansion will ensure the committee has a balanced perspective as they recommend medications purchased by taxpayers through Medicaid and delivered to our most vulnerable individuals.
The work the P & T Committee does is extremely important which is why the committee should include members from the legislature to ensure appropriate oversight. The committee should also be expanded to include community pharmacists as they are the ones on the “front line” who see the impact of pharmaceutical decisions on patients.
Please join me in cosponsoring this important legislation.
Introduced as HB942